ArcheMedX Adds Molly Maple Bryant as Head of Marketing
Charlottesville, VA — May 14, 2020
ArcheMedX today announced the expansion of its leadership team with the addition of Molly Maple Bryant as Head of Marketing. Given the continued success of Ready, the company’s clinical trials platform, this role will enable the ArcheMedX team to capitalize on increased market demand with sponsors and CROs.
In her new position, Bryant is responsible for defining and guiding the organization’s overall marketing and communications strategy, especially its digital channels, ensuring new and consistent business growth for the organization and enhancing brand awareness.
“We’re thrilled to have Molly as part of the ArcheMedX team and believe that her background and unique skill set will greatly benefit our company as we accelerate growth,” said Joel Selzer, CEO. “Her experience marketing software solutions and enterprise services to the life sciences industry will help ArcheMedX increase traction in the rapidly changing clinical research and commercial spaces.”
Prior to joining ArchMedX, Bryant was the VP of Marketing for Seller Labs, leading a team covering demand generation, digital marketing, content marketing, events, and advertising strategy. Before Seller Labs, Ms. Bryant led product marketing for the life sciences division at Cognizant, launching products to a total addressable market of over $1B USD. She also oversaw the external marketing and launch of Cognizant Accelerator, the company’s incubator.
Earlier in her career, Ms. Bryant also worked closely with big names in the life sciences industry, including AmerisourceBergen, McKesson, Pfizer, and Globus Medical, on various technical engagements.
Bryant holds a Bachelor’s of Science degree from the Georgia Institute of Technology and has spent her entire career in high tech. She resides in the Charleston, SC area with her family.
ArcheMedX enables companies across the life sciences and healthcare industries to better equip, evaluate, and predict team and clinician performance, in order to accelerate the development and adoption of new clinical treatments and best practices.
ArcheMedX’s flagship product, Ready, predicts and improves how teams and clinicians will apply knowledge and skills in real-world scenarios. Ready uses behavioral science to enhance how individuals learn and retain information, and delivers actionable insights enabling leaders to identify high performers, potential risks, and areas for improvement.
To learn more about our readiness solutions across clinical operations, commercial, and medical education, visit www.archemedx.com or follow ArcheMedX on LinkedIn.